BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 32639054)

  • 1. Carbonic anhydrase IX (CA9) expression in multiple renal epithelial tumour subtypes.
    Baniak N; Flood TA; Buchanan M; Dal Cin P; Hirsch MS
    Histopathology; 2020 Oct; 77(4):659-666. PubMed ID: 32639054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of the MN/CA9 protein as a reliable diagnostic biomarker of clear cell carcinoma of the kidney.
    Liao SY; Aurelio ON; Jan K; Zavada J; Stanbridge EJ
    Cancer Res; 1997 Jul; 57(14):2827-31. PubMed ID: 9230182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbonic anhydrase IX expression in renal neoplasms: correlation with tumor type and grade.
    Genega EM; Ghebremichael M; Najarian R; Fu Y; Wang Y; Argani P; Grisanzio C; Signoretti S
    Am J Clin Pathol; 2010 Dec; 134(6):873-9. PubMed ID: 21088149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CA9 as a biomarker in preoperative biopsy of small solid renal masses for diagnosis of clear cell renal cell carcinoma.
    Li G; Feng G; Zhao A; Péoc'h M; Cottier M; Mottet N
    Biomarkers; 2017 Mar; 22(2):123-126. PubMed ID: 27775441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of MN/CA9 gene expression in identifying malignant solid renal tumors.
    Li G; Cuilleron M; Cottier M; Gentil-Perret A; Lambert C; Genin C; Tostain J
    Eur Urol; 2006 Feb; 49(2):401-5. PubMed ID: 16387417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant expression of membranous carbonic anhydrase IX (CAIX) is associated with unfavorable disease course in papillary and clear cell renal cell carcinoma.
    Büscheck F; Fraune C; Simon R; Kluth M; Hube-Magg C; Möller-Koop C; Shadanpour N; Bannenberg C; Eichelberg C; Höflmayer D; Clauditz T; Wittmer C; Wilczak W; Sauter G; Fisch M; Rink M; Eichenauer T
    Urol Oncol; 2018 Dec; 36(12):531.e19-531.e25. PubMed ID: 30322727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CA9 as a molecular marker for differential diagnosis of cystic renal tumors.
    Li G; Bilal I; Gentil-Perret A; Feng G; Zhao A; Peoc'h M; Genin C; Tostain J; Gigante M
    Urol Oncol; 2012; 30(4):463-8. PubMed ID: 20822935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expression of carbonic anhydrase IX, PAX2 and PAX8 and their association with clinicopathologic characteristics in renal epithelial tumors].
    Zhang W; Yu WJ; Xia Y; Liu Y; Liu XL; Zhuang J; Li YJ
    Zhonghua Bing Li Xue Za Zhi; 2013 Jul; 42(7):442-5. PubMed ID: 24246861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantification of carbonic anhydrase IX expression in serum and tissue of renal cell carcinoma patients using enzyme-linked immunosorbent assay: prognostic and diagnostic potentials.
    Zhou GX; Ireland J; Rayman P; Finke J; Zhou M
    Urology; 2010 Feb; 75(2):257-61. PubMed ID: 19963243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of carbonic anhydrase IX, α-methylacyl coenzyme a racemase, cytokeratin 7, and galectin-3 in the evaluation of renal neoplasms: a tissue microarray immunohistochemical study.
    Bing Z; Lal P; Lu S; Ziober A; Tomaszewski JE
    Ann Diagn Pathol; 2013 Feb; 17(1):58-62. PubMed ID: 22898056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbonic anhydrase 9 in clear cell renal cell carcinoma: a marker for diagnosis, prognosis and treatment.
    Tostain J; Li G; Gentil-Perret A; Gigante M
    Eur J Cancer; 2010 Dec; 46(18):3141-8. PubMed ID: 20709527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of carbonic anhydrase IX in genitourinary and adrenal tumours.
    Donato DP; Johnson MT; Yang XJ; Zynger DL
    Histopathology; 2011 Dec; 59(6):1229-39. PubMed ID: 22175902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinicopathological study and immunohistochemical expression of CA9 in cystic multilocular renal cell carcinomas].
    Li G; Badin G; Berremila S; Obadia F; Tostain J; Péoc'h M
    Prog Urol; 2012 Sep; 22(10):572-6. PubMed ID: 22920335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic implications of transcription factor Pax 2 protein and transmembrane enzyme complex carbonic anhydrase IX immunoreactivity in adult renal epithelial neoplasms.
    Gupta R; Balzer B; Picken M; Osunkoya AO; Shet T; Alsabeh R; Luthringer D; Paner GP; Amin MB
    Am J Surg Pathol; 2009 Feb; 33(2):241-7. PubMed ID: 18941400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carbonic anhydrase 9 expression in well-differentiated pancreatic neuroendocrine neoplasms might be associated with aggressive behavior and poor survival.
    Kim JY; Lee SH; An S; Kim SJ; Sung YN; Song KB; Hwang DW; Kim SC; Hong SM
    Virchows Arch; 2018 May; 472(5):739-748. PubMed ID: 29666945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CA9 level in renal cyst fluid: a possible molecular diagnosis of malignant tumours.
    Li G; Feng G; Cuilleron M; Zhao A; Gentil-Perret A; Cottier M; Genin C; Tostain J
    Histopathology; 2009 Jun; 54(7):880-4. PubMed ID: 19469910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carbonic anhydrase IX as a specific biomarker for clear cell renal cell carcinoma: comparative study of Western blot and immunohistochemistry and implications for diagnosis.
    Giménez-Bachs JM; Salinas-Sánchez AS; Serrano-Oviedo L; Nam-Cha SH; Rubio-Del Campo A; Sánchez-Prieto R
    Scand J Urol Nephrol; 2012 Oct; 46(5):358-64. PubMed ID: 22571179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal Neoplasms With Overlapping Features of Clear Cell Renal Cell Carcinoma and Clear Cell Papillary Renal Cell Carcinoma: A Clinicopathologic Study of 37 Cases From a Single Institution.
    Dhakal HP; McKenney JK; Khor LY; Reynolds JP; Magi-Galluzzi C; Przybycin CG
    Am J Surg Pathol; 2016 Feb; 40(2):141-54. PubMed ID: 26752401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
    Rabjerg M
    Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reappraisal of Morphologic Differences Between Renal Medullary Carcinoma, Collecting Duct Carcinoma, and Fumarate Hydratase-deficient Renal Cell Carcinoma.
    Ohe C; Smith SC; Sirohi D; Divatia M; de Peralta-Venturina M; Paner GP; Agaimy A; Amin MB; Argani P; Chen YB; Cheng L; Colecchia M; Compérat E; Werneck da Cunha I; Epstein JI; Gill AJ; Hes O; Hirsch MS; Jochum W; Kunju LP; Maclean F; Magi-Galluzzi C; McKenney JK; Mehra R; Nesi G; Osunkoya AO; Picken MM; Rao P; Reuter VE; de Oliveira Salles PG; Schultz L; Tickoo SK; Tomlins SA; Trpkov K; Amin MB
    Am J Surg Pathol; 2018 Mar; 42(3):279-292. PubMed ID: 29309300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.